Neurobo Pharmaceuticals Stock Forecast - Daily Balance Of Power
| NRBODelisted Stock | USD 2.14 0.00 0.00% |
Neurobo Stock Forecast is based on your current time horizon.
Neurobo |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (0.27) | (0.50) |
| Check Neurobo Pharmaceuticals Volatility | Backtest Neurobo Pharmaceuticals | Trend Details |
Neurobo Pharmaceuticals Trading Date Momentum
| On March 27 2024 Neurobo Pharmaceuticals was traded for 4.34 at the closing time. The top price for the day was 4.57 and the lowest listed price was 4.17 . The trading volume for the day was 21.6 K. The trading history from March 27, 2024 was a factor to the next trading day price boost. The trading delta at closing time against the next closing price was 0.93% . The trading delta at closing time against the current closing price is 4.19% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Neurobo Pharmaceuticals to competition
View Neurobo Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Neurobo Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Neurobo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurobo Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Neurobo Pharmaceuticals stock market strength indicators, traders can identify Neurobo Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0645 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 2.1 | |||
| Day Typical Price | 2.11 | |||
| Market Facilitation Index | 0.14 | |||
| Price Action Indicator | 0.04 |
Neurobo Pharmaceuticals Risk Indicators
The analysis of Neurobo Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neurobo Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurobo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.85 | |||
| Standard Deviation | 5.37 | |||
| Variance | 28.84 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Neurobo Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Neurobo Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Neurobo Stock
Moving against Neurobo Stock
| 0.64 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.63 | EC | Ecopetrol SA ADR | PairCorr |
| 0.63 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.59 | AXP | American Express Earnings Call Tomorrow | PairCorr |
| 0.43 | DIS | Walt Disney | PairCorr |
The ability to find closely correlated positions to Neurobo Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Neurobo Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Neurobo Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Neurobo Pharmaceuticals to buy it.
The correlation of Neurobo Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurobo Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurobo Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Neurobo Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Neurobo Stock
If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |